May 8, 2008
ConvaTec to belong to new owners
Private equity firms Avista Capital Partners and Nordic Capital have agreed to acquire biopharmaceutical business unit ConvaTec from Bristol-Myers Squibb Company for approximately $4.1bn, subject to adjustments ... via Pravda
Read full story from Pravda
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| Vioxx claimants rush to join $4.85B settlement ... (from Jan '08) | 41 min | Jerimiah | 686 |
| Claims administrator: Interim payments in $4.85... | 1 hr | Dick In Ohio | 1049 |
| MPI Research cutting jobs in Mattawan | 7 hr | Former MPI E... | 18 |
| Cymbalta leads the way for Lilly (from Feb '07) | 7 hr | Stranger In ... | 234 |
| Merck to fund Vioxx settlement in August | 10 hr | Peggy | 1375 |
| Northwestern Memorial Hospital patient's compla... | 10 hr | Old RN | 2 |
| Johnson & Johnson buying Mentor for $1.07B | 12 hr | Anon Amous | 3 |
Cancer
Most Popular